864 related items for PubMed ID: 18174868
1. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, Oki I, Ogino H, Schonberger LB, Yanagawa H.
Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
[Abstract] [Full Text] [Related]
2. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM, Silverman ED, McCrindle BW, Yeung RS.
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[Abstract] [Full Text] [Related]
3. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[Abstract] [Full Text] [Related]
4. Immunoglobulin failure and retreatment in Kawasaki disease.
Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C.
Pediatr Cardiol; 2003 Dec; 24(2):145-8. PubMed ID: 12457253
[Abstract] [Full Text] [Related]
5. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
[Abstract] [Full Text] [Related]
6. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T.
J Pediatr; 2006 Aug; 149(2):237-40. PubMed ID: 16887442
[Abstract] [Full Text] [Related]
7. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
Khowsathit P, Hong-Hgam C, Khositseth A, Wanitkun S.
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
[Abstract] [Full Text] [Related]
8. Treatment of Kawasaki disease using locally product intravenous immunoglobulin.
Sangtawesin C, Kirawitaya T, Layangkool T, Nawasiri W, Vimolsarawong N.
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S656-60. PubMed ID: 14700163
[Abstract] [Full Text] [Related]
9. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.
Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A.
Circulation; 2006 Jun 06; 113(22):2606-12. PubMed ID: 16735679
[Abstract] [Full Text] [Related]
10. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
Sittiwangkul R, Pongprot Y, Silvilairat S, Phornphutkul C.
Singapore Med J; 2006 Sep 06; 47(9):780-4. PubMed ID: 16924360
[Abstract] [Full Text] [Related]
11. Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin.
Tsai MH, Huang YC, Yen MH, Li CC, Chiu CH, Lin PY, Lin TY, Chang LY.
J Pediatr; 2006 Jan 06; 148(1):38-43. PubMed ID: 16423595
[Abstract] [Full Text] [Related]
12. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
DU ZD, Zhao D, DU JB, Lu S, Yi JM, Hou AC, Zhou ZS, Ding GF, Beijing Kawasaki Disease Epidemilogy Study Grou.
Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3119-21. PubMed ID: 18269869
[Abstract] [Full Text] [Related]
13. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease.
Kuo HC, Yang KD, Liang CD, Bong CN, Yu HR, Wang L, Wang CL.
Pediatr Allergy Immunol; 2007 Jun 27; 18(4):354-9. PubMed ID: 17584314
[Abstract] [Full Text] [Related]
14. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease.
Kobayashi T, Kobayashi T, Morikawa A, Ikeda K, Seki M, Shimoyama S, Ishii Y, Suzuki T, Nakajima K, Sakamoto N, Arakawa H.
J Pediatr; 2013 Aug 27; 163(2):521-6. PubMed ID: 23485027
[Abstract] [Full Text] [Related]
15. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Aug 27; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
16. Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease.
Yanagimoto K, Nomura Y, Masuda K, Hirabayashi M, Morita Y, Yoshishige M, Ueno K, Eguchi T, Kawano Y.
Int Arch Allergy Immunol; 2014 Aug 27; 164(2):83-8. PubMed ID: 24903098
[Abstract] [Full Text] [Related]
17. Initial intravenous gamma-globulin treatment failure in Iranian children with Kawasaki disease.
Kashef S, Safari M, Amin R.
Kaohsiung J Med Sci; 2005 Sep 27; 21(9):401-4. PubMed ID: 16248123
[Abstract] [Full Text] [Related]
18. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
Wooditch AC, Aronoff SC.
Pediatrics; 2005 Oct 27; 116(4):989-95. PubMed ID: 16199713
[Abstract] [Full Text] [Related]
19. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
Manlhiot C, Yeung RS, Chahal N, McCrindle BW.
Pediatr Allergy Immunol; 2010 May 27; 21(3):515-21. PubMed ID: 20546528
[Abstract] [Full Text] [Related]
20. Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).
Lee KY, Han JW, Lee HS, Hong JH, Hahn SH, Lee JS, Whang KT.
Pediatr Infect Dis J; 2004 Jan 27; 23(1):52-5. PubMed ID: 14743047
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
